Erba Diagnostics (ERB) Posts Quarterly Earnings Results
Erba Diagnostics (NYSE:ERB) announced its earnings results on Tuesday. The company reported $0.01 EPS for the quarter, StockRatingsNetwork reports. The company had revenue of $7.54 million for the quarter, compared to the consensus estimate of $6.74 million.
Shares of Erba Diagnostics (NYSE:ERB) opened at 3.03 on Tuesday. Erba Diagnostics has a 52-week low of $0.77 and a 52-week high of $4.13. The stock has a 50-day moving average of $2.16 and a 200-day moving average of $2.21. The company has a market cap of $133.0 million and a price-to-earnings ratio of 134.76.
ERBA Diagnostics, Inc, formerly IVAX Diagnostics, Inc, through its subsidiaries, is engaged in developing, manufacturing and marketing diagnostic test kits, reagents and instruments for use in hospitals, reference laboratories, clinical laboratories, research laboratories, doctors’ offices and other commercial companies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.